Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer

Fig. 1

FLVCR1-AS1 is upregulated in OSC tissues, serum, and cell lines and predicted poor prognosis in OSC. a Expression levels of FLVCR1-AS1 were upregulated in ovarian cancer tissues compared with adjacent nontumor tissues. b Expression levels of FLVCR1-AS1 were upregulated in ovarian cancer serum samples compared with healthy controls. c Correlation of FLVCR1-AS1 expression levels in ovarian cancer tissue and serum. d Expression levels of FLVCR1-AS1 in OSC cell lines compared to the normal human ovarian surface epithelial cells. e The overall survival (OS) rate was significantly lower in patients with high FLVCR1-AS1 expression than in those with low FLVCR1-AS1 expression. f Serum FLVCR1-AS1 expression levels were downregulated in post-operation samples compared with pre-operation ones. Data presented as the mean ± standard deviation (SD) of three independent experiments. *P < 0.05, **P < 0.01

Back to article page